Jiangsu, China

Meiqi Wu

This inventor holds 1 USPTO granted patent. Top assignee: Jiangnan University. Active years: 2020.


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Meiqi Wu in Genetic Engineering

Introduction

Meiqi Wu is a notable inventor based in Jiangsu, China. He has made significant contributions to the field of genetic engineering, particularly through his innovative work on aspartase mutants. His research focuses on enhancing enzyme activity, which has practical applications in industrial production.

Latest Patents

Meiqi Wu holds a patent for an invention titled "Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereof." This invention provides a novel aspartase mutant, a recombinant expression vector, and a recombinant bacterium that contains the aspartase mutant. The invention aims to improve enzyme activity by mutating the amino acid residue at position 427 from glutamic acid to glutamine. This alteration changes the polar environment near the active site, facilitating ammonia supply during substrate reactions and enhancing the enzyme's ability to synthesize β-amino acids. He has 1 patent to his name.

Career Highlights

Meiqi Wu is affiliated with Jiangnan University, where he conducts his research and development activities. His work has garnered attention for its potential impact on the production of β-amino acids, which are valuable in various industrial applications.

Collaborations

Meiqi Wu collaborates with colleagues such as Meijuan Xu and Shuping Xu, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Meiqi Wu's contributions to genetic engineering through his innovative patent demonstrate his commitment to advancing the field. His work not only enhances enzyme activity but also provides practical solutions for industrial applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…